Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

House dust mite allergy vaccine injection - Alk-Abello

Drug Profile

House dust mite allergy vaccine injection - Alk-Abello

Alternative Names: Alutard; Alutard Der p; Alutard SQ; House dust mite SCIT - ALk-Abello; TO-204

Latest Information Update: 26 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ALK-Abello
  • Developer ALK-Abello; Eddingpharm; Torii Pharmaceutical
  • Class Allergens; Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic rhinitis; Asthma

Most Recent Events

  • 24 Jun 2024 ALK-Abello decided to withdraw the Biologic License Application (BLA) for its house dust mite (‘HDM’) sublingual allergy immunotherapy tablet in China.
  • 24 Apr 2014 House dust mite allergy injection licensed to Eddingpharm China
  • 23 Dec 2013 Preregistration for Asthma and Allergic rhinitis in Japan (SC)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top